Bernstein analyst Stacy Rasgon upgrades Analog Devices (NASDAQ:ADI) from Market Perform to Outperform and raises the price target from $165 to $185.
How Is The Market Feeling About Avenue Therapeutics?
Avenue Therapeutics's (NASDAQ:ATXI) short percent of float has risen 168.0% since its last report. The company recently reported that it has 27 thousand shares sold short, which is 3.35% of all regular shares that are available for trading.
